Repligen Corp Targets 10-15% Growth in Proteins with Innovative Resin Products in 2025
Repligen Corporation’s financial performance and strategic growth initiatives in 2025 demonstrate its resilience and adaptability in the biotechnology sector, positioning it for long-term success.
2 minutes to read